<div id="readability-page-1"><div>                     <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/standard-biotools-inc-logo-1200x675.png/query-dj0yMDI0MDUyMTE1MTgyNA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1200" height="675" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/standard-biotools-inc-logo-1200x675.png/query-dj0yMDI0MDUyMTE1MTgyNA"/>Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L acquired 75,000 shares of the business's stock in a transaction on Wednesday, August 13th. The stock was acquired at an average cost of $1.31 per share, for a total transaction of $98,250.00. Following the transaction, the director directly owned 59,466,780 shares in the company, valued at $77,901,481.80. The trade was a 0.13% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through this link.</p><p>Casdin Partners Master Fund, L also recently made the following trade(s): </p><ul><li>On Friday, August 15th, Casdin Partners Master Fund, L purchased 150,000 shares of Standard BioTools stock. The shares were purchased at an average cost of $1.22 per share, for a total transaction of $183,000.00. </li><li>On Thursday, August 14th, Casdin Partners Master Fund, L purchased 133,220 shares of Standard BioTools stock. The shares were purchased at an average cost of $1.21 per share, for a total transaction of $161,196.20. </li></ul><h2>Standard BioTools Stock Performance</h2><p>Standard BioTools stock opened at $1.23 on Friday. The stock has a 50-day moving average of $1.26 and a two-hundred day moving average of $1.20. Standard BioTools Inc. has a one year low of $0.92 and a one year high of $2.32. The stock has a market cap of $467.18 million, a PE ratio of -3.84 and a beta of 1.32. </p><h2>Wall Street Analysts Forecast Growth</h2><hr/><hr/><p>A number of research firms have recently issued reports on LAB. Wall Street Zen raised Standard BioTools from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a research report on Saturday. Cowen cut Standard BioTools from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday. Finally, TD Cowen cut Standard BioTools from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $1.55 price objective for the company. in a research note on Wednesday.</p><p><b>View Our Latest Research Report on Standard BioTools</b></p><h2>Institutional Investors Weigh In On Standard BioTools</h2><p>A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LAB. Two Sigma Securities LLC purchased a new position in shares of  Standard BioTools in the fourth quarter worth about $30,000.  Jump Financial LLC acquired a new position in  Standard BioTools in the 1st quarter worth approximately $26,000.  Aquatic Capital Management LLC acquired a new position in  Standard BioTools in the 4th quarter worth approximately $45,000.  IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its position in  Standard BioTools by 115.6% in the 1st quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 27,119 shares of the company's stock worth $29,000 after purchasing an additional 14,541 shares in the last quarter.  Finally, CWM LLC grew its stake in shares of  Standard BioTools by 101.8% during the 1st quarter. CWM LLC now owns 29,705 shares of the company's stock worth $32,000 after purchasing an additional 14,984 shares during the period. 53.74% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>Standard BioTools Company Profile</h2><p> (Get Free Report)</p><p>Standard BioTools Inc, together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Standard BioTools</li><li>What is the FTSE 100 index? </li><li>MarketBeat Week in Review – 08/11 - 08/15</li><li>Find and Profitably Trade Stocks at 52-Week Lows</li><li>3 Restaurant Stocks That Will Outperform in Q3 and Q4</li><li>Differences Between Momentum Investing and Long Term Investing </li><li>The Midstream Energy Play That Keeps Powering Higher</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEFC?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEFC"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].</em></p>                     <div>                         <p>Insider Buying or Selling at Standard BioTools?</p>                         <p>Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Standard BioTools and related companies.</p>                                                                       </div>                                                               <div>                         <p>From Our Partners</p><div><div><p><img src="https://imageproxy.pbkrs.com/https://s3.us-east-1.amazonaws.com/marketingassets.cloudsna.com/prod/images/brownstoneresearch/et/2025/Colossus+2.jpeg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="800" height="600" original-src="https://imageproxy.pbkrs.com/https://s3.us-east-1.amazonaws.com/marketingassets.cloudsna.com/prod/images/brownstoneresearch/et/2025/Colossus+2.jpeg"/></p><div><p>Musk’s Project Colossus could mint millionaires</p><p>I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...</p><p><span>Brownstone Research</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDM4OA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDM4OA"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://files.admin.agorafinancial.com/Background/AWNTrumpBible.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="820" height="546" original-src="https://imageproxy.pbkrs.com/https://files.admin.agorafinancial.com/Background/AWNTrumpBible.png"/></p><div><p>Genesis 14:13-17 [HIDDEN MEANING?]</p><p>A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...</p><p><span>Paradigm Press</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDMxNA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDMxNA"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2067push_AI-9.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2067push_AI-9.jpg"/></p><div><p>Everyone’s watching Nvidia right now. Here’s why I’m excited.</p><p>So, unless you’ve been living under a rock, you probably saw the news…  Nvidia just signed a $7 BILLION deal...</p><p><span>Timothy Sykes</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDM1NQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDM1NQ"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://files.admin.sovereignsociety.com/Background/gsi_ss_elon450.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="450" height="270" original-src="https://imageproxy.pbkrs.com/https://files.admin.sovereignsociety.com/Background/gsi_ss_elon450.png"/></p><div><p>Elon’s Secret Social Security Bombshell</p><p>To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...</p><p><span>Banyan Hill Publishing</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDMyNg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDMyNg"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2043push_bitcoin-3656764_640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2043push_bitcoin-3656764_640.jpg"/></p><div><p>Crypto Income (almost instantly)</p><p>How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...</p><p><span>Awesomely, LLC</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDIyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDIyMQ"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20250815152843_pushsir-eai-6.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="112" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20250815152843_pushsir-eai-6.jpg"/></p><div><p>Trump's New Plan to “Make China Pay”</p><p>Trump's AI Masterplan Could Crush China  The White House just unleashed would could be the most aggressive e...</p><p><span>Stansberry Research</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDU4Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDU4Mg"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://assets.stansberryresearch.com/uploads/sites/4/2025/08/chart-hdn-buffett-adds-shares.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1920" height="1080" original-src="https://imageproxy.pbkrs.com/https://assets.stansberryresearch.com/uploads/sites/4/2025/08/chart-hdn-buffett-adds-shares.png"/></p><div><p>Is This Stock the 'Next Nvidia'?</p><p>'AI Bottleneck' Now Threatens Entire Magnificent 7  A new critical failure has appeared in the AI market, an...</p><p><span>Altimetry</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDUwNQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDUwNQ"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/20250807152845_unnamed.png/query-MTc1NDU5ODUyNTgyMA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="512" height="312" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/20250807152845_unnamed.png/query-MTc1NDU5ODUyNTgyMA"/></p><div><p>When the levee breaks</p><p>The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...</p><p><span>Porter &amp; Company</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDQ5NA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNDQ5NA"/></p></div></div></div>                     </div>                 </div></div>

<p>Standard BioTools Inc. (NASDAQ:LAB) Director Casdin Partners Master Fund, L purchased 75,000 shares at $1.31 each, totaling $98,250 on August 13. This acquisition increased their ownership by 0.13%, bringing their total shares to 59,466,780, valued at approximately $77.9 million. The director also made additional purchases of 150,000 shares at $1.22 and 133,220 shares at $1.21 shortly after. Analysts have recently adjusted ratings on Standard BioTools, with some downgrading from 'buy' to 'hold'.</p>

Standard BioTools Inc. (NASDAQ:LAB) Director Purchases $98,250.00 in Stock